详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Acute liver failure resulting from discontinuation of nucleoside analogues in chronic hepatitis B patients: A report of two cases

69| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

单位： [1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Infect Dis, Wuhan 430030, Peoples R China

出处：

DOI：

ISSN：

关键词： Chronic hepatitis B nucleoside analogues pathological examination

摘要：

Lamivudine, adefovir, telbivudine, and entecavir are nucleoside analogues that can inhibit hepatitis B virus replication and are licensed in China by the Food and Drug Administration. This study presents the cases of 2 patients who were chronically infected with HBV and suffered hepatic failure resulting from withdrawal of telbivudine and adefovir, respectively.

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2012]版：

大类 | 4 区医学

小类 | 4 区传染病学

最新[2025]版：

无

JCR分区：

出版当年[2011]版：

Q3 INFECTIOUS DISEASES

最新[2023]版：

无

影响因子： 0 最新[2023版] 0 最新五年平均 1.722 出版当年[2011版] 1.669 出版当年五年平均 1.562 出版前一年[2010版] 1.706 出版后一年[2012版]

第一作者：

第一作者单位： [1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Infect Dis, Wuhan 430030, Peoples R China

通讯作者：

通讯机构： [1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Infect Dis, Wuhan 430030, Peoples R China [*1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Infect Dis, 1095 Jiefang Ave, Wuhan 430030, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Real-world evidence for nucleoside/nucleotide analogues in a 5-year multicentre study of antiviral-naive chronic hepatitis B patients in China: 52-week results [2]抗病毒药物对慢性乙型肝炎肝纤维化影响的荟萃分析 [3]慢性乙型肝炎患者血清MIG的表达及核苷类似物对其的影响 [4]Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients [5]Observational Study on Patients With Chronic Hepatitis B [6]Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients [7]Superinfective Hepatitis E Virus Infection Aggravates Hepatocytes Injury in Chronic Hepatitis B [8]Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long-term entecavir [9]EFFORT Extension Study [10]240-week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C